Condition
HLA-A*02:01-positive clinical trials and research
As of November 12, 2026, Find a Trial lists 2 HLA-A*02:01-positive clinical trials that are recruiting, at sites in 7 countries (most in Australia (2), Italy (2), Spain (2)). By phase: Phase 1/2 (1), Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 7Countries
All recruiting trials (2)
-
IMC-P115C treatment for advanced PRAME-positive cancers
This phase 1 study tests a new immune-engaging drug called IMC-P115C, alone or with standard treatments, in people with advanced PRAME-positive, HLA-A*02:01-positive cancers.
-
Testing IMC-R117C for advanced cancers in specific patients
This study is testing a new treatment called IMC-R117C to see if it can help people with advanced cancers like colorectal, esophageal, gastric, or ovarian cancer who have already tried other therapies.
Quick answers
How many HLA-A*02:01-positive clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 7 countries. The most sites are in Australia (2 trials), Italy (2 trials), Spain (2 trials), Belgium (1 trial), Germany (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1/2: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.